GLP-1 Financial Assistance: Every Option for Affordable Weight Loss Medication
Cost should not prevent anyone from accessing effective weight loss treatment. Here is a comprehensive guide to every financial assistance option available for GLP-1 medications in 2026.
Brand-name GLP-1 medications cost $1,000 to $1,600 per month without insurance. That price tag puts effective weight loss treatment out of reach for millions of Americans. But there are multiple pathways to affordable access. From compounded alternatives to patient assistance programs to tax strategies, this guide covers every option available for making semaglutide and tirzepatide affordable.
Disclaimer
Program availability and eligibility requirements change frequently. Verify current information directly with each program. This is not financial advice.
The Most Affordable Option: Compounded GLP-1 Medications
For most patients, compounded GLP-1 medications represent the most accessible pathway. Compounding pharmacies produce semaglutide and tirzepatide at a fraction of brand-name costs because they are not subject to the same patent pricing structures. Trimi offers compounded semaglutide at $99/mo and tirzepatide at $125/mo, representing savings of 90% or more compared to brand-name pricing.
Compounded medications contain the same active ingredient, are prescribed by licensed providers, and are dispensed by licensed pharmacies. They are a legitimate, legal, and medically appropriate option for patients who cannot afford or access brand-name versions.
Manufacturer Patient Assistance Programs
Brand-Name Assistance Programs
Novo Nordisk PAP (Wegovy/Ozempic)
- For uninsured patients with income below 400% of federal poverty level
- Provides free medication for up to 12 months
- Requires application with income verification
- Apply at NovoCare.com or call 1-888-809-3942
Lilly Cares (Mounjaro/Zepbound)
- For uninsured patients meeting income criteria
- Provides medication at no cost or reduced cost
- Application through healthcare provider
- Visit LillyCares.com for details
Insurance Strategies
If your current insurance does not cover GLP-1 medications, consider these approaches. Request a prior authorization with a letter of medical necessity from your provider. Appeal any denials, as many are overturned on appeal. Check if your employer can add anti-obesity medication coverage during the next benefit renewal. During open enrollment, compare plans specifically for GLP-1 coverage. And if you are self-employed, marketplace plans may offer better coverage than individual plans.
Tax-Advantaged Strategies
Combined Tax Savings Potential
- HSA payment: Save 22-37% through pre-tax contributions (up to $4,300 individual)
- FSA payment: Save 30%+ including FICA tax savings (up to $3,200)
- Medical expense deduction: Deduct costs exceeding 7.5% of AGI on Schedule A
- Combined approach: Use HSA/FSA for medication and deduct remaining medical expenses
State-Level Programs
Some states offer pharmaceutical assistance programs that may cover GLP-1 medications. State Medicaid programs have varying formularies; check yours at Medicaid.gov. Some states have prescription drug assistance programs for low-income residents not qualifying for Medicaid. State employee health plans increasingly cover anti-obesity medications. Contact your state's Department of Health for available programs.
Nonprofit and Community Resources
NeedyMeds.org maintains a database of patient assistance programs searchable by medication. RxAssist.org provides a comprehensive directory of pharmaceutical assistance programs. Patient advocacy organizations like the Obesity Action Coalition offer resources and support for accessing treatment. Community health centers may offer sliding-scale pricing for medical consultations related to weight management.
Your Action Plan for Affordable GLP-1
Step-by-Step Guide
- Step 1: Check if your insurance covers GLP-1 medications
- Step 2: If not covered, explore compounded options (Trimi at $99-$125/mo)
- Step 3: Set up HSA or FSA payment for pre-tax savings
- Step 4: If income-eligible, apply for manufacturer patient assistance
- Step 5: Track all medical expenses for potential tax deductions
- Step 6: Check state-specific programs and community resources
The Bottom Line
No one should be priced out of effective weight loss treatment. Between compounded alternatives at $99/mo, tax-advantaged payment strategies, patient assistance programs, and the natural food savings that occur on GLP-1 medications, affordable access is achievable for most patients willing to explore their options.
The Most Affordable GLP-1 Treatment
Trimi: semaglutide $99/mo, tirzepatide $125/mo. No insurance needed.
Get StartedMore on financial strategies
Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before starting any medication or treatment program.
Sources & References
- Wilding JPH et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. NEJM 2021;384:989-1002.
- Jastreboff AM et al. Tirzepatide Once Weekly for the Treatment of Obesity. NEJM 2022;387:205-216.
- Lincoff AM et al. Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes. NEJM 2023;389:2221-2232.
- FDA Prescribing Information for Wegovy (semaglutide) and Zepbound (tirzepatide).